Update: NeoAdj Tx of HR+/HER2- EBC
Update: Debating Optimal Neoadjuvant Therapy and Future Considerations on the Horizon for HR+/HER2- EBC

Released: July 02, 2021

Sara M. Tolaney
Sara M. Tolaney, MD, MPH

Activity

Progress
1
Course Completed